Table 3. Features of Study and Control... | American Society of Hematology

Table 3.

Features of Study and Control Groups

	Study (1)	Historic (2)	CyA/MTX (3)	Significance
	Study (1)	Historic (2)	CyA/MTX (3)	P₁₂	P₁₃
No. of patients	70	50	459
Median year of transplant	92 (87-96)	86 (84-94)	90 (84-95)	<.001	<.001
Median follow-up (months)	44	116	58	<.001	.01
Male patient	57%	38%	50%	.04	.24
Male donor	61%	52%	54%	.34	.29
Median age at transplant	36 (14-50)	30 (14-47)	31 (14-56)	.003	.03

	Study (1)	Historic (2)	CyA/MTX (3)	Significance
	Study (1)	Historic (2)	CyA/MTX (3)	P₁₂	P₁₃
No. of patients	70	50	459
Median year of transplant	92 (87-96)	86 (84-94)	90 (84-95)	<.001	<.001
Median follow-up (months)	44	116	58	<.001	.01
Male patient	57%	38%	50%	.04	.24
Male donor	61%	52%	54%	.34	.29
Median age at transplant	36 (14-50)	30 (14-47)	31 (14-56)	.003	.03

The extreme range of the data is shown in parentheses. Probabilities (P) are calculated by the χ² test or Wilcoxon two-sample test as appropriate.